Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase III trial of Minocycline topical Gel (HY01) in patients with Papulopustular Rosacea

Trial Profile

Phase III trial of Minocycline topical Gel (HY01) in patients with Papulopustular Rosacea

Status: Planning
Phase of Trial: Phase III

Latest Information Update: 24 Sep 2019

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Minocycline (Primary)
  • Indications Rosacea
  • Focus Therapeutic Use
  • Acronyms MARS-3

Most Recent Events

  • 24 Sep 2019 New trial record
  • 20 Sep 2019 According to a Hovione media release, the company anticipates initiating this trial subject to entering into a strategic collaboration with a commercial partner by fourth quarter of 2 aiming at filing the NDA during 2021.
  • 20 Sep 2019 According to a Hovione media release, the company received guidance for the design and clinical endpoints for HY01 at a recent End-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA).

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top